Hansa Biopharma AB (publ) (STO: HNSA)

Hansa Biopharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,743	1,374	2,581	3,949	10,691	3,356
Market Cap Growth	37.70%	-46.77%	-34.64%	-63.06%	218.56%	-69.66%
Enterprise Value	4,013	1,396	2,157	2,963	9,221	2,687
Last Close Price	55.20	26.20	49.22	88.80	240.40	83.85
PE Ratio	-	-1.66	-3.62	-7.20	-24.09	-9.32
PS Ratio	18.64	10.25	16.70	116.57	1753.27	997.68
PB Ratio	-14.34	-8.18	4.28	5.21	8.61	5.96
P/FCF Ratio	-4.22	-1.82	-5.10	-8.17	-36.79	-9.95
P/OCF Ratio	-4.22	-1.82	-5.13	-8.21	-36.83	-10.03
EV/Sales Ratio	24.53	10.41	13.96	87.45	1512.21	798.81
EV/EBITDA Ratio	-4.91	-1.78	-3.76	-5.51	-21.84	-7.56
EV/EBIT Ratio	-4.89	-1.77	-3.74	-5.49	-21.69	-7.51
EV/FCF Ratio	-5.39	-1.85	-4.26	-6.13	-31.74	-7.96
Debt / Equity Ratio	-4.45	-5.16	1.31	0.05	0.00	0.02
Debt / FCF Ratio	-1.31	-1.15	-1.56	-0.07	-0.02	-0.03
Asset Turnover	0.14	0.10	0.11	0.03	0.01	0.00
Inventory Turnover	40.48	50.80	63.34	90.74	-	-
Quick Ratio	3.04	2.57	5.91	5.33	12.13	6.41
Current Ratio	3.05	2.66	6.06	5.50	12.20	6.51
Return on Equity (ROE)	-	-382.37%	-89.84%	-54.84%	-46.63%	-50.61%
Return on Assets (ROA)	-37.86%	-36.43%	-26.67%	-27.56%	-25.32%	-27.78%
Return on Capital (ROIC)	-50.21%	-47.09%	-32.93%	-33.06%	-29.20%	-31.20%
Earnings Yield	-26.30%	-60.53%	-23.68%	-13.88%	-3.94%	-10.73%
FCF Yield	-19.87%	-55.02%	-19.61%	-12.24%	-2.72%	-10.06%
Buyback Yield / Dilution	-12.91%	-16.95%	-1.01%	-5.45%	-5.39%	-4.42%
Total Shareholder Return	-12.91%	-16.95%	-1.01%	-5.45%	-5.39%	-4.42%

Source: S&P Capital IQ. Standard template. Financial Sources.